- Home
- PMVP vs ANL Comparison
PMVP vs ANL Comparison
Compare PMVP & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- ANL
- Stock Information
- Founded
- PMVP 2013
- ANL 2004
- Country
- PMVP United States
- ANL Cayman Islands
- Employees
- PMVP N/A
- ANL N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- ANL
- Sector
- PMVP Health Care
- ANL
- Exchange
- PMVP Nasdaq
- ANL Nasdaq
- Market Cap
- PMVP 85.5M
- ANL 84.5M
- IPO Year
- PMVP 2020
- ANL 2023
- Fundamental
- Price
- PMVP $1.51
- ANL $2.22
- Analyst Decision
- PMVP Strong Buy
- ANL Strong Buy
- Analyst Count
- PMVP 4
- ANL 2
- Target Price
- PMVP $5.75
- ANL $9.00
- AVG Volume (30 Days)
- PMVP 196.4K
- ANL 9.6K
- Earning Date
- PMVP 11-07-2024
- ANL 08-08-2024
- Dividend Yield
- PMVP N/A
- ANL N/A
- EPS Growth
- PMVP N/A
- ANL N/A
- EPS
- PMVP N/A
- ANL N/A
- Revenue
- PMVP N/A
- ANL $5,000,000.00
- Revenue This Year
- PMVP N/A
- ANL N/A
- Revenue Next Year
- PMVP N/A
- ANL N/A
- P/E Ratio
- PMVP N/A
- ANL N/A
- Revenue Growth
- PMVP N/A
- ANL N/A
- 52 Week Low
- PMVP $1.40
- ANL $1.85
- 52 Week High
- PMVP $3.47
- ANL $17.48
- Technical
- Relative Strength Index (RSI)
- PMVP 38.59
- ANL 43.45
- Support Level
- PMVP $1.55
- ANL $2.23
- Resistance Level
- PMVP $1.61
- ANL $2.44
- Average True Range (ATR)
- PMVP 0.07
- ANL 0.19
- MACD
- PMVP -0.01
- ANL -0.01
- Stochastic Oscillator
- PMVP 18.18
- ANL 23.43
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.